Topical Corticosteroids (e.g., Clobetasol) / Topical Tacrolimus

Treatment for Pyoderma

Typical Dosage: Apply 1-2 times daily

Effectiveness
65%
Safety Score
70%
Clinical Trials
15
Participants
300

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Apply 1-2 times daily
Time to Effect
2-4 weeks
Treatment Duration
Weeks to months, often intermittent long-term
Evidence Quality
MODERATE
Confidence Score
70%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$800
Monitoring:$200
Side Effect Mgmt:$50
Total Annual:$1,050
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$3,500/QALY
QALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$2,100
Cost per Remission
$5,250
Prescription Access Economics
Annual Societal Loss per Patient
$-4,725
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$375/year
Time Cost
$180/year
Travel + wait time
Insurance Admin Cost
$160/year
Prior auth, claims
Rx Price
$800/year
Potential OTC Price
$240/year
Estimated if OTC available
Early Treatment Benefit
+0.10 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
MODERATE
Topical Corticosteroids (e.g., Clobetasol) / Topical Tacrolimus Outcomes

for Pyoderma

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+50%
Remission Rate
+20%
Common Side Effects
Skin atrophy
+15%
Telangiectasias
+10%
Burning/Stinging
+5%
Irritation
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov